首页 | 本学科首页   官方微博 | 高级检索  
     


Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)
Authors:Robert P. Whitehead  Cathryn Rankin  Paulo M. G. Hoff  Philip J. Gold  Kevin G. Billingsley  Robert A. Chapman  Lucas Wong  John H. Ward  James L. Abbruzzese  Charles D. Blanke
Affiliation:(1) Medical University of South Carolina, 96 Jonathan Lucas Street, Suite 903 Clinical Science Building, MSC 635, Charleston, SC 29425-6350, USA;(2) Southwest Oncology Group Statistical Center, Seattle, WA, USA;(3) Instituto do Cancer de Sao Paulo, Sao Paulo, Brazil;(4) Swedish Cancer Institute, Seattle, WA, USA;(5) Oregon Health and Science University, Portland, OR, USA;(6) Henry Ford Hospital, Detroit, MI, USA;(7) Scott & White Clinic, Temple, TX, USA;(8) University of Utah Health Sciences Center, Salt Lake City, UT, USA;(9) M.D. Anderson Cancer Center, Houston, TX, USA;(10) University of British Columbia, Vancouver, BC, Canada
Abstract:
Keywords:
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号